Gut microbiota modulation by Traditional Chinese Medicine: a translational strategy for metabolic dysfunction-associated steatotic liver disease

BackgroundMetabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as a critical global health burden, driven by rising prevalence rates and earlier disease onset. Current therapeutic strategies remain limited to lifestyle interventions, with no approved pharmacotherapies targeti...

Descripció completa

Dades bibliogràfiques

Autors principals:	Ting Zhou, Ziwen Jin, Rilei Jiang, Weiwei Li
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2025-06-01
Col·lecció:	Frontiers in Pharmacology
Matèries:	metabolic dysfunction-associated steatotic liver disease gut microbiota Traditional Chinese Medicine gut-liver axis bile acid metabolism
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1600439/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!